Nomad Power Solutions, Inc. NMAD

No quarterly revenue total was found in NOMAD POWER SOLUTIONS, INC.'s SEC filings.

Nomad Power Solutions, Inc. (NMAD) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $12.7 million in cash and investments and $1.1 million in total debt.

Revenue
—
Net income
$-2.34M
-17.9% vs prior quarter
Operating cash flow
$-1.61M
-230.6% vs year-ago quarter
Free cash flow
—
EPS
$-0.16
+11.1% vs prior quarter
Dividend per share
None
Shares outstanding
16.10M
+253.0% vs year-ago quarter
Net cash
$11.57M
Q2 FY2026
Operating margin
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NMAD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1335105
Former names
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (until Jul 2, 2026); SRKP 7 INC (until Dec 1, 2006)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Operating income
-$2.3M
-$2.0M
Net income
-$2.3M
-$2.0M
Diluted EPS
-$0.16
-$0.18
Operating cash flow
-$1.6M
-$1.8M
Total assets
$26.6M
$10.9M
Total liabilities
$1.7M
$1.7M
Stockholders' equity
$23.9M
$7.9M
Cash and investments
$12.7M
$3.3M
Total debt
$1.1M
$1.1M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 6, 2026 Oct 6, 2026
8-K Current report
Material agreement, Unregistered share sale
Sep 30, 2026 Sep 28, 2026
8-K/A Amended current report Sep 17, 2026 Jul 1, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 31, 2026 Jul 31, 2026
8-K Current report
Regulation FD disclosure
Jul 10, 2026 Jul 8, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.